Decentralized Clinical Trials | Defining DCTs
Decentralized clinical trials (DCTs) exploded in popularity after the COVID-19 pandemic, and they have now become a permanent part of the clinical trial landscape.
Read Blog
Blog Posts | Florence
Explore all blog articles.
-
-
What do patients think about decentralized clinical trials?
Research sites and sponsors can’t stop talking about decentralized clinical trials (DCTs). But we often forget to ask a vital question: how do patients feel about them? As of 2021, 95% of...
Read Blog
-
Improving Patient Retention in Clinical Trials
Patient retention in clinical trials is one of the largest challenges facing sites, sponsors, and CROs. The Center for Information and Study on Clinical Research Participation found that 23% of...
Read Blog
-
15 Great Clinical Research Coordinator Interview Questions
When deciding on Clinical Research Coordinator (CRC) interview questions, research sites need to think about how the role is changing. Gone are the days when a Clinical Research Coordinator (CRC)...
Read Blog
-
Acronyms and Abbreviations for Clinical Research You Need to Know
There are dozens of abbreviations for clinical trial terms. What’s the difference between a CRA, a CRC, and a CRO? How about the difference between eISF, ePRO, and eTMF? If you’ve been in medical...
Read Blog
-
Join Our Newsletter To Get Top Clinical Research News and Resources
Subscribe Now -
Diversity in Decentralized Clinical Trials | Why it’s Important and How to Improve
Many medical professionals worry about a lack of diversity in clinical trials, and this lack can have medical consequences. A 2014 study showed that around 20% of new drugs approved between 2008...
Read Blog
-
Supporting Ukraine Clinical Trials During a Time of War
Ukraine clinical trials continue to suffer because of Russia’s invasion. When the war began, clinical trial activity had to be frozen. While some trials have resumed and some international trials...
Read Blog
-
EU Annex 11: How to Stay Compliant
EU Annex 11 lays out the European Union’s regulations for using computerised systems during clinical trials. Any sponsor or site who wants their new medical treatment approved in the EU must...
Read Blog
-
FDA 21 CFR Part 11 Compliance: Guidelines for FDA-Governed Industries
Many clinical trial sites want to use technology but worry about compliance, especially 21 CFR Part 11 compliance. Using technology that isn’t compliant can lead to audits and stressful...
Read Blog
-
How to Improve Patient Diversity in Clinical Trials
Research sites struggle with patient diversity in their clinical trials, and this can have a negative impact on treatment outcomes. In 2018, African American people made up 13.4% of the U.S....
Read Blog
-
How Technology Can Empower CAR T-Cell Therapy Clinical Trials
CAR T-cell therapy clinical trials are among the most exciting medical advances of the past decade. Since 2017, the FDA has approved 6 CAR T-cell treatments for blood cancers, including lymphomas,...
Read Blog
-
Florence Supports Diversity in Clinical Trials Through a Partnership with the Meharry-Vanderbilt Alliance
Florence Healthcare is committed to supporting Diversity, Equity & Inclusion (DE&I) initiatives in clinical trials, both through the use of its software and philanthropic investment in the...
Read Blog
-
Medicaid coverage of clinical trials will improve inclusion: but there’s more work to do
On Jan. 1, 2022, the Clinical Trial Treatment Act went into effect, requiring all U.S. states and territories to cover routine clinical trial costs for Medicaid patients. Medicaid coverage of...
Read Blog
-
How sites and sponsors can collaborate for a smooth site feasibility process
The site feasibility process is broken. The average clinical trial coordinator spends 264 hours a year completing feasibility questionnaires for sponsors. Yet 80% of clinical trial sites still...
Read Blog
-
The role of clinical trial technology in creating and managing frontier sites
Historically, clinical trials have been concentrated at academic medical centers, large hospitals, and cancer centers. But under this approach, trials aren’t as inclusive or accessible as they...
Read Blog
-
How Global Clinical Trial Regulations Impact Healthcare Technology
When searching for clinical trial software, every site, sponsor and CRO has the same question: “how does this software comply with (insert clinical trial regulation here)?” Research professionals...
Read Blog
-
Five Capabilities You Need in an eTMF
These five capabilities will propel your eTMF beyond a document repository to an effective platform for accelerating your clinical trials.
Read Blog
-
5 Facts You Should Know About Patient-facing Technology
Patient-facing technology can make trials more accessible and help trials fit into participants’ lives. But if we’re not careful, technology built to empower patients may end up overwhelming them...
Read Blog
-
How Community Sites Can Improve the Lack of Diversity in Clinical Trials
The lack of diversity in clinical trials is one of the most pressing concerns confronting the clinical research industry. The recent FDA guidance for diversity in clinical trials calls on all...
Read Blog
-
Why Clinical Trial Translations Matter
When clinical trial sites, sponsors and tech vendors think about diversity and inclusion, we consider a variety of factors: age, race, ethnicity, gender identity, sexual orientation, ability, and...
Read Blog
-
Loading More...
